search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
REGULATIONS 47


Acrylates copolymers The Cosmetic Ingredient Review expert panel assessed the safety of 126 acrylates copolymers; 70 of these were reviewed for the first time; 56 had been reviewed previously by the panel. The panel concluded that all 126 acrylates copolymers are safe in cosmetic products in the present practices of use and concentrations as described in their safety assessment when formulated to be non-irritating.14


Hydroxyethyl urea The Cosmetic Ingredient Review expert panel has assessed the safety of Hydroxyethyl Urea in cosmetic products and has concluded that it is safe in the current practices of use and concentration as described in their safety assessment when formulated to be non-irritating.15


Vinylpyrrolidone Acrylate Copolymers, Polyvinylpyrrolidones and modified Polyvinylpyrrolidones, Vinylpyrrolidone Crosspolymers and some urethanes. Vinyl pyrrolidone polymers are used as film formers, rheology modifiers and binders. They declared that 27 vinylpyrrolidones are safe in cosmetic products in the present practices of use and concentrations as described in their safety assessment. There was insufficient information to determine the safety of the 3 urethanes.


It is


used as a humectant and as a hair and skin conditioning agent in cosmetic products. The Cosmetic Ingredient Review expert panel assessed its use at up to 20.6% in leave-on products. No concentrations were given for its use in rinse-off products.


Vinylpyrrolidone polymers The Cosmetic Ingredient Review expert panel reviewed the safety of 30 vinylpyrrolidones.16


included Vinylpyrrolidone Copolymers,


Methylxanthines The Cosmetic Ingredient Review expert panel reviewed the safety of methylxanthines and concluded that Caffeine, Theophylline and Theobromine are safe to use in cosmetic products in the present practices of use and concentrations assessed in their safety assessment.17


The


panel considered the use of Caffeine at up to 6% in leave–on products and 0.37% in rinse–off products.


The vinylpyrrolidones


European Union In 2018 the European Cosmetics Regulation (EC) No 1223/2009 was amended three times. The European Commission used commission regulations to make these amendments. Also Regulation (EC) No 1907/2006 (REACH) was amended by


Commission Regulation (EU) 2018/35 to limit the use of Cyclotetrasiloxane and Cyclopentasiloxane in rinse–off cosmetic products.


Commission Regulation (EU) 2018/885


Commission Regulation (EU) 2018/885 amends Regulation (EC) No 1223/2009 for Methylene bis-Benzotriazolyl Tetramethylbutylphenol, a UV filter listed in annex VI (entry 23) and permits its use in nano form (annex VI, entry 23a). Methylene bis-Benzotriazolyl Tetramethylbutylphenol in nano form can be used up to a maximum concentration of 10% provided it is not in products that can be inhaled in to the lungs. Purity, solubility and median particle size criteria apply to Methylene bis- Benzotriazolyl Tetramethylbutylphenol in nano form. It must also have a partition coefficient (log Pow) of 12.7 at 25°C and be uncoated. If both nano and non nano Methylene bis-Benzotriazolyl Tetramethylbutylphenol are used in the same formulation the sum of both concentrations must not exceed 10%.


Commission Regulation (EU) 2018/978


Commission Regulation (EU) 2018/978 prohibits the use of Tagetes Erecta Flower


  





 


    


May 2019 PERSONAL CARE NORTH AMERICA


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88